A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor
- DOI
- 10.1016/j.ygyno.2026.07.017
- Published
- 2026-09
- Container
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ygyno.2026.07.017,
title = {A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor},
author = {Elizabeth E. Hopp and Danielle Enserro and Susana Campos and Viola Chitiyo and Gloria Huang and Heather Lankes and Erin K. Crane and Anna Hoekstra and Jean Siedel and Debra L. Richardson and Carol Aghajanian and Janet S. Rader and Allan Covens},
year = {2026},
journal = {Gynecologic Oncology},
doi = {10.1016/j.ygyno.2026.07.017},
url = {https://doi.org/10.1016/j.ygyno.2026.07.017}
}RIS
TY - JOUR TI - A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor AU - Elizabeth E. Hopp AU - Danielle Enserro AU - Susana Campos AU - Viola Chitiyo AU - Gloria Huang AU - Heather Lankes AU - Erin K. Crane AU - Anna Hoekstra AU - Jean Siedel AU - Debra L. Richardson AU - Carol Aghajanian AU - Janet S. Rader AU - Allan Covens PY - 2026 JO - Gynecologic Oncology DO - 10.1016/j.ygyno.2026.07.017 UR - https://doi.org/10.1016/j.ygyno.2026.07.017 ER -
APA
Hopp, E. E., Enserro, D., Campos, S., Chitiyo, V., Huang, G., Lankes, H., Crane, E. K., Hoekstra, A., Siedel, J., Richardson, D. L., Aghajanian, C., Rader, J. S., & Covens, A. (2026). A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2026.07.017
Source records
- crossref · retrieved 2026-09-25T18:41:57.324Z